Fonte: Neuro-Oncology. Unidade: FMRP
Assuntos: ESTUDOS DE COORTES, METILAÇÃO DE DNA, NEOPLASIAS HIPOFISÁRIAS, PROGNÓSTICO
ABNT
MOSELLA, Maritza Queiroz Salas et al. DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features. Neuro-Oncology, v. 23, n. 8, p. 1292-1303, 2021Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noab044. Acesso em: 18 nov. 2024.APA
Mosella, M. Q. S., Sabedot, T. S., Silva, T. C., Malta, T. M., Dezem, F. S., Asmaro, K. P., et al. (2021). DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features. Neuro-Oncology, 23( 8), 1292-1303. doi:10.1093/neuonc/noab044NLM
Mosella MQS, Sabedot TS, Silva TC, Malta TM, Dezem FS, Asmaro KP, Wells M, Mukherjee A, Poisson LM, Snyder J, Carvalho AC de, Walbert T, Aho T, Kalkanis S, Elias PCL, Antonini SRR, Rock J, Noushmehr H, Castro M de, Castro AV. DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features [Internet]. Neuro-Oncology. 2021 ; 23( 8): 1292-1303.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1093/neuonc/noab044Vancouver
Mosella MQS, Sabedot TS, Silva TC, Malta TM, Dezem FS, Asmaro KP, Wells M, Mukherjee A, Poisson LM, Snyder J, Carvalho AC de, Walbert T, Aho T, Kalkanis S, Elias PCL, Antonini SRR, Rock J, Noushmehr H, Castro M de, Castro AV. DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features [Internet]. Neuro-Oncology. 2021 ; 23( 8): 1292-1303.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1093/neuonc/noab044